Anti-D Rh0 immunoglobulin - Biotest

Drug Profile

Anti-D Rh0 immunoglobulin - Biotest

Alternative Names: Anti-D immune globulin - Biotest; Anti-D polyclonal antibody; Nabi Anti-D; Rh0 (D) Immune Globulin Intravenous (Human)

Latest Information Update: 10 Aug 2018

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Nabi Biopharmaceuticals
  • Developer Biotest Pharmaceuticals
  • Class Immunoglobulins
  • Mechanism of Action Platelet activating factor stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Discontinued Idiopathic thrombocytopenic purpura

Most Recent Events

  • 01 Aug 2018 Biotest Pharmaceuticals has been acquired by Grifols Shared Services North America
  • 31 Dec 2006 Phase-I clinical trials in Idiopathic thrombocytopenic purpura in USA (IV)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top